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Purpose. This trial was designed to evaluate the efficacy and safety of topical honey eye drops in patients with diagnosed VKC.
Methods. This clinical trial was conducted on 60 patients with diagnosed VKC. The patients were selected and randomly allocated
between two groups of 30. Patients in two groups received honey eye drop (60% in artificial tear) or placebo, other than cromolyn
and fluorometholone 1% eye drops, to be used topically in each eye, four times per day. The patients were examined with slit
lamp and torch at baseline and the follow-up visits on the 1st, 3rd, and 6th months of the study for redness, limbal papillae, and
intraocular pressure. Results. Out of 60 patients who completed the study, 19 patients (31.7%) were female. There was significant
increase in eye pressure and reduction in redness as well as limbal papillae, following the consumption of the honey drop in honey
group compared to placebo control group (𝑃 < 0.05). At the end of trial, one patient in honey group and 7 ones in placebo group
had limbal papillae (𝑃 < 0.05). Conclusion. Topical honey eye drops, when used along with Cromolyn and Fluorometholone eye
drops, might be beneficial for the treatment of VKC.
1. Introduction
Vernal keratoconjunctivitis (VKC) is a seasonal recurrent dis-
easewhich is considered as an inflammatory or allergic ocular
disease. It is mostly seen in children and young adults and
the incidence of disease is high in spring and summer [1, 2].
Vernal keratoconjunctivitis has been reportedmostly in trop-
ical countries such as Pakistan and may cause difficulties for
the cornea and conjunctiva [2, 3].
Patients usually complain about severe eye irritation,
photophobia, chemosis, tearing, and excessive mucus secre-
tions that lead to stick eyelash edges. Large amounts of IgE
and secreted proteins of eosinophils are found in the tears
of patients with vernal keratoconjunctivitis [4, 5]. Many fine
papillae can be seen in inferior tarsal conjunctiva. There are
giant papillae in upper eyelid conjunctiva that create a paving
appearance [6].
Therapeutic options for this disease include topical
steroids, antihistamines, and mast cell stabilizers. Mast cell
stabilizers are preferred because of fewer side effects [7]. The
most important and the most serious side effect of steroids is
high eye pressurewhich ultimatelymay lead to glaucoma aris-
ing in patients with genetic predisposition. Other side effects
can include cataract and secondary infection. About ten per-
cent of the patients will be inflicted with corneal ulcers which
may lead to decreased vision due to corneal changes. Other
patients’ ocular difficulties may lead to glaucoma, cataract, or
large corneal pannus [6].
Recently the use of alternative and complementary
medicine has been increasing [8]. During the last decade the
number of people who has tried alternative and complemen-
tary medicine is nearly doubled and the numbers remain
on the rise [9]. Furthermore, promising results have been
released for alternative therapy in various kinds of diseases
[10, 11].
Honey has been used in the treatment of eye diseases as
medicine for thousands of years. Nowadays, more attention is
paid to it because of numerous and suitable reports about the
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properties of honey. It has antibacterial and antifungal effects
on awide range ofmicroorganisms. Furthermore,with regard
to the decrease of the efficacy of antibiotics due to resistant
strains and resistance to antibiotics which is a serious threat
to global health, the efficacy of such honey has been proven
effective in improving eye diseases [12]. For instance, it is used
in the treatment of corneal bacterial ulcers, catarrhal kera-
toconjunctivitis, syphilis keratitis, corneal calcareous burns,
other keratitis, keratoconjunctivitis, corneal infections, and
chemical and thermal eye burns [13]. Due to the side effects
of available drugs in keratoconjunctivitis and weak curative
effects, this study was designed with the aim of determining
the effect of the honey drop on keratoconjunctivitis in order
to find out a way to reduce consumption of steroids in these
patients.
2. Materials and Method
This clinical trial study was done on 60 patients referred to
the ophthalmology clinic in Shahrekord, Iran. The patients
were examined and selected by an ophthalmologist based on
history and clinical examinations. Patients who had mild,
moderate, or severe kinds of keratoconjunctivitis, had no
other ocular diseases, and had not previously received any
treatment for keratoconjunctivitis were included to reduce
the impact of potential confounders. They were attended in
the study with personal satisfaction. Patients who had other
ocular problems or complications were excluded from the
study. The sampling method was based on convenience sam-
pling. Patients were randomly allocated between two groups
of 30. The sample size was calculated based on a 95% confi-
dence and a power of 80% to see a reduction of redness from
65% to 30% in the case group. The sample size was obtained
as 30 patients in each group.
Patients in first group received fluorometholone drop
(1%) and sodium cromolyn along with honey drops (60%
honey in artificial tears) and patients in second group
received fluorometholone and sodium cromolyn along with
artificial tear. All patients were asked to use 1 drop from each
of the mentioned treatments every 6 hours for 1 month. Dur-
ing the study period, patients were initially examined once
a week for the first month of the study and then 3 and 6
months from the first visit. Patients were examined by slit
lamp in terms of symptoms such as redness of the eye, limbal
papillae, intraocular pressure, and visual acuity.
Throughout the study research the tenets of the Declara-
tion of Helsinki [14] were followed and informed consent was
obtained. The research was approved by Ethical Committee
and review board of Shahrekord University of Medical Sci-
ence. Power analysis was performed to justify the number of
patients enrolled in the study.
Results were presented based on the percentage for
qualitative variables and mean and standard deviation for
quantitative variables. Statistical analysis was done using
independent and paired t-tests and Chi-square or Fisher’s
exact tests by SPSS. 𝑃 < 0.05 was considered statistically
significant.
Table 1: The mean of eye pressure in two groups.
Involvement eye Steps Experimental Control Sig.∗
Right
Before 13.03 (1.69) 13.27 (2.24) 0.651
After 14 (1.36) 16.43 (2.20) 0.001
Sig.∗∗ 0.001 0.001 —
Left
Before 13.27 (1.33) 13.10 (2.32) 0.735
After 14.30 (1.26) 16.77 (2.30) 0.001
Sig.∗∗ 0.001 0.001 —
∗Between two groups sig. Independent 𝑡-test was used.
∗∗Before and after sig. Paired 𝑡-test was used.
The redness in both left and right eyes was improved in patients of group 1
who received honey drop compared to control group (Table 2).
3. Results
In this clinical trial, all 60 patients completed the study in
two groups of experimental (𝑛 = 30) and control (𝑛 = 30).
Nineteen (31.7%) patients were female and the rest weremale.
The sex difference was not observed between the two groups
(𝑃 < 0.05).
Eye pressure results of patients’ left and right eyes in both
groups are summarized in Table 1. In group 1, the left and
right eye pressure were significantly increased after the study
but it was in normal range.
There was a significant difference in the amount of right
eye limbal papillae in experimental group compared to con-
trol group after study (𝑃 < 0.05), representing 100% recovery
of the right eye. In left eye, only one person fromexperimental
group had limbal papillae after study while 7 ones in control
group had limbal papillae. Generally, the amount of limbal
papillae in experimental group was significantly decreased
during the study (𝑃 < 0.05) (Table 3).
4. Discussion
This study aimed to determine the effect of honey drop on the
symptoms of vernal keratoconjunctivitis and it was designed
to findout away to reduce the amount of corticosteroid usage.
The results of this study showed that the use of honey drop
in the treatment of vernal keratoconjunctivitis caused eye
redness to improve, the limbal papillae to reduce, and allergic
symptoms to improve. Allergic reactions are created as
a result of the severe response to allergic materials.
It has been suggested that the most important participat-
ing cells in vernal keratoconjunctivitis are eosinophils. Some-
times, white spots are seen in conjunctiva and cornea due to
the accumulation of inflammatory cells. Anti-inflammatory
effect of honey onwound tissues has been observed bymicro-
scopic studies with reduction in white blood cells, such as
eosinophils, involved in inflammation [6].
Topical steroids as primary treatment for swollen eye or
vernal keratoconjunctivitis are widely used with remarkable
effect in improving symptoms such as intense itching, pho-
tophobia, and tearing. However, prolonged use of topical
steroids leads to increase of the risk of cataracts; corneal thin-
ning; and fungal, viral, and bacterial infections. All of these
conditions can lead to blindness [2].
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Table 2: Frequency of the intensity of redness in patients’ eyes in both groups.
Eye Step Redness Experimental Control Sig.
Right
Before study
Normal 9 6
0.165Severe 21 21
More severe 0 3
After study
Without redness 13 0
0.001Low 13 1
Normal 3 15
Severe 1 14
Left
Before study
Normal 10 5
0.111Severe 20 22
More severe 0 3
After study
Without redness 15 0
0.001Low 12 2
Normal 3 15
Severe 0 13
Table 3: Comparison of limbal papillae in the experimental and control groups.
Step Experimental group Control group Sig.
Number Percent Number Percent
Right eye Before study 16 53.3 14 46.7 0.60
After study 0 0 13 43.3 0.001
Left eye Before study 18 60 11 36.7 0.071
After study 1 3.33 7 23.3 0.052
In this study, using a honey drop (60%) had great impact
on the reduction of eye redness and improvement of limbal
papillae compared to control group. It has been reported that
honey can reduce inflammation, edema, and exudate removal
[15]. Considering that vernal keratoconjunctivitis is an aller-
gic inflammatory disease of the eye, possibly honey has
been effective in improving symptoms by reducing inflam-
mation. Previous investigations have concluded that honey
might be a good remedy for ocular wounds and it is used as a
panacea for eye diseases [16, 17].
Honey has antibacterial effect and can be used to prevent
corneal scarring caused by infection [17, 18]. Healing of
bacterial corneal wound has been reported by honey. Honey
can also probably be effective in improving the scars after
infections [19, 20].The anti-inflammatory effect of honey has
caused it to be used in the treatment of blepharitis (inflam-
mation of the eyelid margins) and keratitis (corneal inflam-
mation) [21].
Honey has clear antioxidant property and cause free radi-
cals to neutralize. Antioxidant activity could be one reason for
the anti-inflammatory effect of honey. Because oxygen free
radicals are involved in different inflammatory conditions
[22–24], antioxidants, especially the natural ones, are able
to reduce inflammation [25–27]. Even if honey antioxidants
cannot completely suppress inflammation, it can reduce its
damage and possibly be effective in improving the symptoms
of vernal keratoconjunctivitis.
In clinical trials like this, the patient compliance is very
important. The viscosity of honey drop is more than tear
and its usage may cause inconvenience for a few seconds.
Although this might have caused a limitation; however, the
results show that the majority of patients might have used
their medications.
There was significant increase in eye pressure following
the consumption of the honey drop in honey group compared
to placebo control group (𝑃 < 0.05). At the end of trial one
patient in honey group and 7 ones in placebo group had
limbal papillae (𝑃 < 0.05).
The results showed that drop of honey can be effective in
reduction of redness and limbal papillae and in improving the
vernal keratoconjunctivitis. It might be used to reduce the
amount of steroid consumption. However, more research is
needed to determine how much it can reduce the need for
steroid usage.
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